GHRL and colorectal carcinoma: Low serum levels of ghrelin have further been found to be associated with an increased risk of the development of CRC [42] and experimental studies with mice have shown that ghrelin administration can suppress inflammation-induced colorectal carcinogenesis [43,44,45].